3 The neutralization of IL-17A correlates with JNK inhibitor in vitro protection from EAE3 and IL-17-deficient mice are resistant to both EAE13 and CIA.14 While the IL-23/Th17 axis is important in experimental autoimmune pathology, it is believed to have evolved to provide protective adaptive immunity to specific classes of extracellular pathogens including infections of bacterial Klebsiella pneumonia,15Streptococcus pneumonia16 and Citrobacter rodentium17
as well as fungal Cryptococcus neoformans18 and Candida albicans.19 Murine Th17 cells do not express Th1 (T-bet) and Th2 (GATA-3) transcription factors but instead require the orphan retinoid nuclear receptor (ROR)γt for their differentiation.20 Another related nuclear receptor, RORα is believed to act synergistically with RORγt to induce complete Th17 differentiation.21 Lineage commitment of Th17 cells from naive T cells is induced by the combination of transforming growth factor (TGF)-β and IL-6 cytokines,22 while IL-2317 and IL-123 play an important role in its survival and expansion. Recent studies have shown Angiogenesis inhibitor that these Th17 cells also provide an autocrine signal via the secretion of IL-21, which is important for Th17 differentiation.24,25 The identification of TGF-β as a component of Th17 inducers reciprocally linked Th17 cells with immunosuppressive
T regulatory (Treg) cells; whereby the additional presence of IL-6 enhanced Th17 development and its absence led to diminished Th17 responses and a peripheral repertoire dominated by Treg cells.25 Th17 differentiated cells produce IL-17A, IL-17F, IL-21, IL-22, TNF, IL-6 and IL-9.3,26–28 In humans, IL-17A-producing Th memory cells have been identified and characterized. These cells express the human orthologue of mouse RORγt, and like mouse Th17 cells are responsive to IL-2329 and their differentiation is dependent on TGF-β and IL-21.30 Interleukin-17A and IL-17F belong to the family of IL-17 cytokines Selleckchem Idelalisib and can both bind to the IL-17RA receptor,31 which has a broad tissue distribution.32 Both IL-17A and IL-17F are pleiotropic pro-inflammatory mediators that can induce various pro-inflammatory
cytokines/chemokines including: CXCL8, IL-6, CCL2, TNF-α, IL-1β, G-CSF and GM-CSF.33 IL-17A and IL-17F are also implicated in the upregulation of intercellular adhesion molecule-1, which mediates the chemotaxis of neutrophils to sites of infection.34 IL-17A-producing cells are present in diseased kidneys, where IL-17A acts synergistically with CD40L, a protein expressed on activated T cells, to induce primary human renal epithelial cells to secrete higher levels of IL-6, IL-8 and monocyte chemotactic peptide-1 as well as complement component C3.35,36 It is now known that IL-17A and IL-17F are chiefly produced by activated and memory CD4+ Th cells37 but its production has also been demonstrated by γδ T cells,38 CD8+ memory T cells,39 eosinophils,40 neutrophils41 and monocytes.